Globus Medical (GMED) Reports Preliminary Sales Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
Globus Medical (GMED) PT Raised to $101 at Canaccord Genuity
January 10, 2025 6:37 AM ESTCanaccord Genuity analyst William J. Plovanic raised the price target on Globus Medical (NYSE: GMED) to $101.00 (from $92.00) while maintaining a Buy rating.
The analyst comments "Model Update: We are updating our model post GMED's Q4/24 preannouncement last evening. As a reminder, last night GMED... More



